Microbubble-Mediated Blood-Brain Barrier Opening via Focused Ultrasound
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biomarkers and therapeutic agents for neurological disorders face limited in vivo efficacy due to their inability to cross the blood-brain barrier, as they are excluded by the barrier's passive and metabolic transport mechanisms, rendering them ineffective in reaching their intended targets.
Innovation Solution
The use of microbubbles in conjunction with focused ultrasound to create acoustic cavitation events, which temporarily open the blood-brain barrier, allowing for the targeted delivery of medicinal molecules and biomarkers by selecting appropriate acoustic parameters such as pulse length, frequency, and pressure to control the extent and location of tissue opening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the blood-brain barrier is opened using high intensity ultrasound, then the delivery of therapeutic agents is improved, but the damage to microvasculature increases
Solution Approach 1:
The patent introduces microbubbles as an intermediary substance that mediates between the ultrasound energy and the blood-brain barrier. These microbubbles serve as acoustic contrast agents that amplify the mechanical effects of ultrasound at the vessel wall interface, enabling barrier opening at lower ultrasound intensities that would otherwise be insufficient. The microbubbles absorb and concentrate acoustic energy locally, acting as a force multiplier that reduces the need for high-power ultrasound while achieving the same therapeutic effect.
Solution Approach 2:
The patent utilizes acoustic cavitation events controlled by specific acoustic parameters (frequency, pressure amplitude, pulse duration) to temporarily alter the physical state of the blood-brain barrier. By adjusting these parameters, the system creates controlled mechanical stress that reversibly opens tight junctions between endothelial cells, allowing therapeutic agents to pass through. The barrier returns to its closed state after the ultrasound ceases, minimizing permanent damage.
2Productivity
If the acoustic parameter is increased to open the tissue more effectively, then the opening efficiency is improved, but the control precision over the opening location and extent deteriorates
Solution Approach 1:
The patent applies ultrasound energy locally to specific target regions by focusing the acoustic beam at a precise focal point within the brain. The microbubbles are distributed systemically but only those at the focal point experience sufficient acoustic pressure to undergo cavitation and open the barrier. This localized application allows high opening efficiency at the target while maintaining precise spatial control, as the effect is confined to the focal zone where both the ultrasound intensity and microbubble concentration are sufficient.
Solution Approach 2:
The patent employs acoustic cavitation, a form of mechanical vibration, where microbubbles oscillate rapidly in response to ultrasound pressure waves. This violent oscillation and subsequent collapse generates localized mechanical stress that opens the blood-brain barrier. By controlling the acoustic parameters (frequency, amplitude, pulse structure), the system precisely regulates the intensity and duration of this mechanical vibration, thereby controlling both the efficiency of opening and the spatial extent of the effect.
3Reliability
If microbubbles are injected systemically to ensure coverage of the target region, then the reliability of barrier opening is improved, but the time required for microbubble positioning increases
Solution Approach 1:
The patent administers microbubble injection in advance of the ultrasound treatment, allowing sufficient time for the microbubbles to circulate and distribute throughout the cerebral vasculature before the focused ultrasound is applied. This preliminary positioning ensures that when the ultrasound focal point is activated, microbubbles are already present at the target location, guaranteeing reliable cavitation and barrier opening. The timing is coordinated so that the peak microbubble concentration at the target coincides with the ultrasound delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the targeted and controlled opening of the blood-brain barrier, enhancing the delivery of molecules up to megaDalton size range, improving the efficacy of therapeutic agents while minimizing potential damage to the microvasculature and maintaining safety.
Implementation Method 1
The acoustic parameter can be selected to control an acoustic cavitation event
Implementation Method 2
a transducer, coupled to the targeting assembly, for applying an ultrasound beam to the targeted region
Data Source
Figure 1
Figure 2
Figure 3(a)
AI summary
Systems and methods for opening a tissue to a target value using microbubbles are disclosed herein. In an embodiment of a method for opening a tissue to a target value using microbubbles, a region of the tissue is targeted for opening, an acoustic parameter corresponding to the target value is determined, and an ultrasound beam is applied to the target region at the acoustic parameter such that the tissue at the target region is opened to the target value with the microbubbles. The acoustic parameter can be selected to control an acoustic cavitation event and, in some embodiments, controlling an acoustic cavitation event can include controlling a location, number and/or magnitude of acoustic cavitation events.